Keyphrases
Cell Signaling Pathways
100%
Pharmacological Targets
100%
Guinea pig
100%
Airway Smooth muscle Cells
100%
Kv7 Potassium Channels
100%
Bronchodilator Therapy
100%
Intermediate Target
100%
Human Aortic Smooth muscle Cells (HASMCs)
66%
Airway
50%
Kv7 Channels
50%
Human Lung
33%
Quantitative PCR
33%
Histamine
33%
Bronchoconstrictor
33%
Channel Activator
33%
Lung Slice
33%
XE991
33%
Flupirtine
33%
Electrophysiological Characteristics
16%
Patch-clamp Electrophysiology
16%
Current Amplitude
16%
Elevated Concentrations
16%
Channel Blocker
16%
Calcium Channel Blockers
16%
Constriction
16%
Celecoxib
16%
Verapamil
16%
Methacholine
16%
Pharmacological Attributes
16%
Airway Constriction
16%
Voltage-gated Potassium Channel
16%
Kv7.2
16%
Precision-cut Lung Slices
16%
Dimethyl-celecoxib
16%
Retigabine
16%
KCNQ Genes
16%
Medicine and Dentistry
Bronchodilating Agent
100%
Airway Smooth Muscle Cell
100%
Pharmacological Target
100%
Potassium Channel
100%
Signal Transduction
100%
Lung Slice
37%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Bronchoconstricting Agent
25%
Flupirtine
25%
10,10 Bis(4 Pyridinylmethyl) 9(10h) Anthracenone
25%
Histamine
25%
Celecoxib
25%
Channel Blocker
12%
Methacholine
12%
Calcium Channel Blocking Agent
12%
Verapamil
12%
Retigabine
12%
Ligation
12%
Airway Constriction
12%
Electrophysiology
12%
Patch Clamp
12%
Pharmacology, Toxicology and Pharmaceutical Science
Guinea Pig
100%
Bronchodilating Agent
100%
Potassium Channel
100%
Celecoxib
33%
Bronchoconstricting Agent
33%
10,10 Bis(4 Pyridinylmethyl) 9(10h) Anthracenone
33%
Histamine
33%
Flupirtine
33%
Channel Blocker
16%
Methacholine
16%
RNA Directed DNA Polymerase
16%
Calcium Channel Blocker
16%
Verapamil
16%
Airway Constriction
16%
Retigabine
16%